Point72 Hong Kong’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,713
Closed -$1.48M 810
2023
Q4
$1.48M Buy
+6,713
New +$1.55M 0.09% 240
2021
Q4
Sell
-6,733
Closed -$1.24M 2423
2021
Q3
$1.24M Buy
6,733
+6,554
+3,661% +$1.29M 0.04% 654
2021
Q2
$32K Sell
179
-3,555
-95% -$677K ﹤0.01% 1562
2021
Q1
$625K Buy
+3,734
New +$623K 0.02% 799
2020
Q3
Sell
-48
Closed -$6K 1554
2020
Q2
$6K Buy
+48
New +$5.4K ﹤0.01% 1030
2020
Q1
Sell
-806
Closed -$71K 1377
2019
Q4
$71K Sell
806
-84
-9% -$7.39K 0.02% 608
2019
Q3
$71K Sell
890
-4,635
-84% -$373K 0.02% 515
2019
Q2
$431K Buy
+5,525
New +$517K 0.12% 143
2018
Q3
Sell
-2
Closed 1184
2018
Q2
$0 Buy
+2
New +$220 ﹤0.01% 1203
2018
Q1
Sell
-28
Closed -$4K 1170
2017
Q4
$4K Buy
28
+16
+133% +$2.03K ﹤0.01% 627
2017
Q3
$1K Sell
12
-70
-85% -$8.94K ﹤0.01% 733
2017
Q2
$11K Buy
+82
New +$10.2K 0.01% 465
2017
Q1
Sell
-16
Closed -$2K 1002
2016
Q4
$2K Buy
+16
New +$2.04K ﹤0.01% 793
2016
Q2
Sell
-200
Closed -$22K 671
2016
Q1
$22K Buy
+200
New +$25.3K 0.04% 270
2014
Q4
Sell
-75
Closed -$10K 663
2014
Q3
$10K Buy
+75
New +$7.73K 0.01% 246

Other funds holding UTHR

Point72 Hong Kong's UTHR Position: Q1 2024 in Review

Point72 Hong Kong sold out of United Therapeutics (UTHR) in Q1 2024, closing a stake of 6,713 shares — an estimated $1.48M sold.

Point72 Hong Kong first reported a position in UTHR in Q3 2014 and held it in 15 quarters. The position peaked at $1.48M in Q4 2023. 525 funds tracked by Wall St. Rank hold UTHR as of Q1 2024.

  • Point72 Hong Kong reported no remaining United Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 6,713 United Therapeutics shares in Q1 2024, an estimated $1.48M.
  • Point72 Hong Kong first reported a position in United Therapeutics in Q3 2014 and held it in 15 quarters.
  • Point72 Hong Kong's United Therapeutics position peaked at $1.48M in Q4 2023.
  • 525 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2024.

Based on Point72 Hong Kong's 13F filing for Q1 2024, filed 15 May 2024.